Skip to main content
Back to Menlo Ventures

Menlo Ventures's Biotechnology Portfolio

Browse 19 Biotechnology companies funded by Menlo Ventures. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
19
Total Funding in Biotechnology
$2.2B

Biotechnology Portfolio Companies (19)

Export
BiopharmaBiotechnologyHealth Care

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

Menlo Park, United States
August 2022
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

Palo Alto, United States
July 2022
$225.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMachine LearningPharmaceutical

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Lexington, United States
June 2022
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Alameda, United States
June 2026
$25.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

H1 is on a mission to connect the world to the right doctor

New York, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyInformation Technology

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

South San Francisco, United States
May 2026
$40.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

South San Francisco, United States
May 2026
$10.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

South San Francisco, United States
April 2024
$1.0B
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsIndustrial AutomationInnovation ManagementLife ScienceMachine LearningSoftware

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Redwood City, United States
February 2022
$200.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncology

Earli develops genetic constructs for early cancer detection and targeted therapy.

South San Francisco, United States
August 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsLife ScienceMedical

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

Seattle, United States
June 2024
$21.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsGeneticsHealth CareHealth DiagnosticsPrecision Medicine

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

San Francisco, United States
August 2023
$1.2M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalRecruitingTherapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

South San Francisco, United States
January 2023
$287.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct Research

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Boston, United States
December 2024
$75.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Big DataBiotechnologyHealth Diagnostics

Clear Labs is a biotechnology firm that integrates a genomics system to simplify diagnostics for the clinical and application sectors.

San Carlos, United States
January 2025
$30.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceSoftware

Benchling is an IT company that provides a cloud-based software platform for biology researchers and research and development organizations.

San Francisco, United States
November 2021
Series F

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Epiodyne is a Provider of Biotechnology Research.

San Francisco, United States
March 2021
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareTherapeutics

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

South San Francisco, United States
March 2021
Series D

Founder Contacts

30,000+ verified contacts

Explore Menlo Ventures's Full Portfolio

View all companies funded by Menlo Ventures across every industry and funding stage.

View Full Menlo Ventures Portfolio